The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2013;(3): 37‑41

Read: 3817 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2013;(3):37‑41. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Fitzpatrick A.L., Daling J.R., Furberg C.D., et al. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997;80:1438-1447.
  2. Largent J.A., McEligot A.J., Ziogas A., et al. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006;20:727-732.
  3. Largent J.A., Bernstein L., Horn-Ross P.L., et al. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control 2010;21:1615-1624.
  4. Li C.I., Malone K.E., Weiss N.S., et al. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003;98;1504-1513.
  5. Fryzek J.R. Poulsen A.H., Lipworth L., et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 2006;97:231-236.
  6. Jick H., Jick S., Derby L.E., et al. Calcium-channel blockers and risk of cancer. Lancet 1997;349:525-528.
  7. Meier C.R., Derby L.E., Jick S.S., Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 2000;160:349-353.
  8. Michels K.B., Rosner B.A., Walker A.M., et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer 1998;83:2003-2007.
  9. Olsen J.H., Sorensen H.T., Friis S., et al. Cancer risk in users of calcium channel blockers. Hypertension 1997;29:1091-1094.
  10. Pahor M., Guralnik J.M., Ferrucci L., et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996:348:493-497.
  11. Rosenberg L., Rao R.S., Palmer J.R., et al. Calcium-channel blockers and the risk of cancer. JAMA 1998;279:1000-1004.
  12. Sorensen H.T., Olsen J.H., Mellemkjaer L., et al. Cancer risk and mortality in users of calcium channel blockers: a cohort study. Cancer 2000;89:165-170.
  13. Boudreau D.M., Daling J.R., Malone K.E., et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004;159:308-317.
  14. Singh A., Bangalore S. Which, if any, antihypertensive agents cause cancer? Curr Opin Cardiol 2012;27(4):374-380.
  15. Coogan P.F. Non-hormonal medications and chronic diseases. In: Li CI, ed. Breast Cancer Epidemiology. New York, NY: Springer; 2010:243-260.
  16. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
  17. Brown M.J., Palmer C.R., Castaigne A., et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000;356:366-372.
  18. Lindholm L.H., Anderson H., Ekbom T., et al. Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet 2001;358:539-544.
  19. Coogan P.F. Calcium-Channel Blockers and Breast Cancer: A Hypothesis Revived. JAMA Intern Med 2013 Aug 5. doi: 10.1001/jamainternmed.2013.9069. [Epub ahead of print]
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.